Massivemarkets

NTHI

NeOnc Technologies Holdings, Inc. Common Stock

Nasdaq · usd

$2.86-0.41 (-12.70%)
As of 2:04:35 PM EDT on Oct 26, 2026 · 15-minute delayed

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) trades at $2.86 (-12.70%) as of 2:04:35 PM EDT on Oct 26, 2026, -13.75% over the past month. Market cap is $94.19M, with 3.9 days to cover in short interest.

Stock performance

How NeOnc Technologies Holdings, Inc. Common Stock (NTHI) stock has performed from one day to one year, with its 52-week range.

-9.37%
-$0.29 over 1D
$2.90$3.13$3.35$3.578:15 AM10:10 AM11:20 AM12:40 PM2:00 PM$2.86
1D
-12.69%
1W
+4.96%
1M
-13.75%
YTD
-65.48%
1Y
-65.35%
52-wk range
$2.50 – $12.00

Key statistics

Today's trading snapshot for NTHI: day range, open, previous close, volume and market cap.

Day range
$2.85 – $3.62
Open
$3.27
Prev close
$3.27
Volume
157.13K
Market cap
$94.19M
Shares out
26.19M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for NeOnc Technologies Holdings, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
-5.08
P/FCF
—
ROE
254.7%
ROA
-902.2%
Debt/Equity
0.00
Div yield
0.00%

As of Oct 23, 2026

8-K filings

Material corporate events NeOnc Technologies Holdings, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On October 16, 2026, NeOnc Technologies Holdings, Inc. issued a press release announcing early clinical improvement in its first patient treated in Abu Dhabi, United Arab Emirates, with investigational intranasal NEO100 through the Company's Compassionate Care program.

  • Director appointmentOct 15, 2026

    Effective October 9, 2026, the Board appointed Ali Mohammad Ahmad Alabedin as a director of the Company. Mr. Alabedin will serve as a Class I director until the Company's annual meeting of stockholders in 2029.

  • Charter amendmentSep 21, 2026

    On September 18, 2026 (the "Effective Date"), the Company filed an Elimination of Certificate of Designation with the Secretary of State of the State of Delaware to terminate the designation of its Series A Preferred Stock (the "Certificate of Elimination").

  • Underwriting agreementSep 10, 2026

    Roth Capital Partners, LLC and A.G.P/Alliance Global Partners acted as placement agents for the Offering pursuant to a placement agency agreement dated September 8, 2026. Pursuant to the Placement Agency Agreement, the Company has agreed to pay the Placement Agents a cash fee equal to 7.0% of the gross proceeds received by the Company in the Offering.

  • Annual meeting resultsAug 20, 2026

    NeOnc Technologies Holdings, Inc. held its 2026 annual meeting of stockholders on August 14, 2026. The Company's stockholders elected two Class I directors, approved amendment of the Company's 2023 Equity Incentive Plan, ratified the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm, and approved adjournment of the Annual Meeting with detailed voting results provided for each proposal.

NTHI short interest

How heavily NTHI is shorted: shares short, days to cover and average daily volume.

Days to cover
3.9
Short interest
757.74K
Avg volume
192.99K

As of · reported to FINRA twice monthly.

NTHI news

The latest news and headlines about NeOnc Technologies Holdings, Inc. Common Stock (NTHI).

Frequently asked questions

What is the NeOnc Technologies Holdings, Inc. Common Stock (NTHI) stock price today?

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is trading at $2.86 (-12.70% on the day) as of 2:04:35 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is NeOnc Technologies Holdings, Inc. Common Stock?

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases.

What is the short interest in NTHI?

As of Sep 30, 2026, NTHI has 757.74K shares short and 3.9 days to cover.

What exchange is NTHI listed on?

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of NTHI with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NTHI analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.